Apple's sophisticated Pages, Numbers, and Keynote apps are free and work seamlessly across the company's devices, though we ...

CBSE defers March 9 to 11 Class 12th board exams in the Middle East; new dates soon –Short Writing: In notices and invitations, strictly adhere to the box and word limit (50 words). Formal invitations ...

While previous embedding models were largely restricted to text, this new model natively integrates text, images, video, audio, and documents into a single numerical space — reducing latency by as muc ...

T20 World Cup: Jasprit Bumrah's death-over yorkers turned England's World Cup dream into dust at the Wankhede. From hallway ...

Upstream Bio said a Phase 2 clinical trial for its respiratory-disease treatment met its primary endpoint in two dosing regimens, but that a third treatment group didn't see consistent improvements.

Nuvation Bio earns a modest Buy at ~$5, supported by the steady adoption of IBTROZI, its lead asset, by patients and prescribers alike during the last 7 months. IBTROZI's patient starts stabilized at ...

The Global Alzheimer’s Platform Foundation ® (GAP) is pleased to welcome Spear Bio, a biotechnology company pioneering wash-free ultrasensitive immunoassay technology, to the Bio-Hermes-002 study.

Artificial intelligence is moving quickly into drug discovery as pharmaceutical and biotech companies look for ways to cut years off R&D timelines and increase the chances of success amid rising costs ...

Jan 6 (Reuters) - Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic data to discover new drug candidates to send into human ...

For many years, the landscape of data center innovation has been dominated by solid-state electronics. The relentless pursuit of faster chips, denser racks and larger facilities has been the mantra ...

The MarketWatch News Department was not involved in the creation of this content. Results from the Precision-T study showed Orca-T significantly improved survival free from chronic GvHD in patients ...